Cardiovascular changes in patients with primary aldosteronism after surgical ormedical treatment

Journal of Endocrinological Investigation

Volumn 35, Issue 3, 2012, Pages 274-280

  Bernini, G ^a,b   Bacca, A ^a   Carli, V ^a   Carrara, D ^a   Materazzi, G ^a   Berti, P ^a   Miccoli, P ^a   Pisano, R ^a   Tantardini, V ^a   Bernini, M ^a   Taddei, S ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Aldosterone receptors blockade; Cardiovascular changes; Primary aldosteronism; Surgery

Indexed keywords

ALDOSTERONE;

ADULT; AGED; ARTICLE; BODY MASS; CARDIOVASCULAR SYSTEM; DIASTOLIC BLOOD PRESSURE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE MASS; HUMAN; MAJOR CLINICAL STUDY; MALE; PHARMACEUTICAL CARE; PLASMA RENIN ACTIVITY; PRIMARY HYPERALDOSTERONISM; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENAL HYPERPLASIA, CONGENITAL; ADULT; AGED; ALDOSTERONE; BLOOD PRESSURE; CARDIOVASCULAR PHYSIOLOGICAL PROCESSES; FOLLOW-UP STUDIES; HUMANS; HYPERALDOSTERONISM; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MIDDLE AGED; PROSPECTIVE STUDIES; RISK FACTORS; YOUNG ADULT;

EID: 84859543472     PISSN: 03914097     EISSN: 17208386     Source Type: Journal    
DOI: 10.3275/7611     Document Type: Article

References (27)

1. Rossi GP, Bernini G, Caliumi C, et al; PAPY Study Investigators. A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients. J Am Coll Cardiol 2006, 48: 2293-300.
2. Lemarié CA, Paradis P, Schiffrin EL. New insights on signaling cascades induced by cross- talk between angiotensin II and aldosterone. J Mol Med 2008, 86: 673-8.
3. Milliez P, Girerd X, Plouin PF, Blacher J, Safar ME, Mourad JJ. Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism. J Am Coll Cardiol 2005, 45: 1243-8.
4. Catena C, Colussi G, Nadalini E, et al. Cardiovascular outcomes in patients with primary aldosteronism after treatment. Arch Intern Med 2008, 168: 80-5.
5. Mulatero P, Caserta M, Bertello C, et al. Aldosterone as an independent factor in cerebrovascular damage. Clin Exp Hypertens 2008, 30: 785-97.
6. Born-Frontsberg E, Reincke M, Rump LC, et al. Cardiovascular and cerebrovascular comorbidities of hypokalemic and normokalemic primary aldosteronism: results of the German Conn's registry. J Clin Endocrinol Metab 2009, 94: 1125-30.
7. Giacchetti G, Ronconi V, Turchi F, et al. Aldosterone as a key mediator of the cardiometabolic syndrome in primary aldosteronism: an observational study. J Hypertens 2007, 25: 177-86.
8. Fallo F, Federspil G, Veglio F, Mulatero P. The metabolic syndrome in primary aldosteronism. Curr Diab Rep 2008, 8: 42-7.
9. Iacobellis G, Petramala L, Cotesta D, et al. Adipokines and cardiometabolic profile in primary hyperaldosteronism. J Clin Endocrinol Metab 2010, 95: 2391-8.
10. Meria P, Kempf BF, Hermieu JF, Plouin PF, Duclos JM. Laparoscopic management of primary hyperaldosteronism: clinical experience with 212 cases. J Urol 2003, 169: 32-5.
11. Lumachi F, Ermani M, Basso SM, Armanini D, Iacobone M, Favia G. Long-term results of adrenalectomy in patients with aldosterone-producing adenomas: multivariate analysis of factors affecting unresolved hypertension and review of the literature. Am Surg 2005, 71: 864-9.
12. Pang TC, Bambach C, Monaghan JC, et al. Outcomes of laparoscopic adrenalectomy for hyperaldosteronism. ANZ J Surg 2007, 77: 768-73.
13. Catena C, Colussi G, Lapenna R, et al. Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism. Hypertension 2007, 50: 911-8.
14. Rossi GP, Bolognesi M, Rizzoni D, et al. Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients. Hypertension 2008, 51: 1366-71.
15. Mulatero P, Bertello C, Rossato D, et al. Roles of clinical criteria, computed tomography scan, and adrenal vein sampling in differential diagnosis of primary aldosteronism subtypes. J Clin Endocrinol Metab 2008, 93: 1366-71.
16. Bernini G, Moretti A, Orlandini C, et al. Plasma and urine aldosterone to plasma renin activity ratio in the diagnosis of primary aldosteronism. J Hypertens 2008, 26: 981-8.
17. Rossi GP, Belfiore A, Bernini G, et al; PAPY Study Investigators. Prospective evaluation of the saline infusion test for excluding primary aldosteronism due to aldosterone-producing adenoma. J Hypertens 2007, 25: 1433-42.
18. Schirpenbach C, Seiler L, Maser-Gluth C, et al. Confirmatory testing in normokalaemic primary aldosteronism: the value of the saline infusion test and urinary aldosterone metabolites. Eur J Endocrinol 2006, 154: 865-73.
19. Agharazii M, Douville P, Grose JH, Lebel M. Captopril suppression versus salt loading in confirming primary aldosteronism. Hypertension 2001, 37: 1440-3.
20. Castro OL, Yu X, Kem DC. Diagnostic value of the post-captopril test in primary aldosteronism. Hypertension 2002, 39: 935-8.
21. Mancia G, De Backer G, Dominiczak A, et al. 2007 ESH-ESC Practice Guidelines for the Management of Arterial Hypertension: ESH-ESC Task Force on the Management of Arterial Hypertension. J Hypertens 2007, 25: 1105-87.
22. Henry WL, DeMaria A, Gramiak R, et al. Report of the American Society of Echocardiography Committee on Nomenclature and Standards in Two-dimensional Echocardiography. Circulation 1980, 62: 212-7.
23. Devereux RB, Reichek N. Echocardiographic determination of left ventricular mass in man. Anatomic validation of the method. Circulation 1977, 55: 613-8.
24. Rossi GP, Pitter G, Bernante P, Motta R, Feltrin G, Miotto D. Adrenal vein sampling for primary aldosteronism: the assessment of selectivity and lateralization of aldosterone excess baseline and after adrenocorticotropic hormone (ACTH) stimulation. J Hypertens 2008, 26: 989-97.
25. Muiesan ML, Salvetti M, Paini A, et al. Inappropriate left ventricular mass in patients with primary aldosteronism. Hypertension 2008, 52: 529-34.
26. Rossi GP, Sacchetto A, Pavan E, et al. Remodeling of the left ventricle in primary aldosteronism due to Conn's adenoma. Circulation 1997, 95: 1471-8.
27. Sywak M, Pasieka JL. Long-term follow-up and cost benefit of adrenalectomy in patients with primary hyperaldosteronism. Brit J Surg 2002, 89: 1587-93.